To continue reading this article, please Login or Sign up for FREE below. You will be sent an email with a password.
This year marks the ten-year anniversary of the women’s health initiative study regarding HRT in postmenopausal women. The US Preventive Services task force came out this week with recommendations about the use of estrogen and progestin treatment in postmenopausal women. The new recommendations are based on data reviewed and published Monday (May 28, 2012) in the Annals of Internal Medicine. This article covered the analysis of 9 clinical trials over the last 10 years. The recommendations were based on whether hormone therapy should be used by postmenopausal women to prevent possible future health events such as heart disease, dementia or osteoporosis. The overall consensus is that HRT should not be used in postmenopausal women for prevention of such conditions. They